| AHA/ASA focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: a guideline for healthcare … WJ Powers, CP Derdeyn, J Biller, CS Coffey, BL Hoh, EC Jauch, ... Stroke 46 (10), 3020-35, 2015 | 1991 | 2015 |
| Predicting survival in pulmonary arterial hypertension: insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL) RL Benza, DP Miller, M Gomberg-Maitland, RP Frantz, AJ Foreman, ... Circulation 122 (2), 164-172, 2010 | 1801 | 2010 |
| 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding … WJ Powers, CP Derdeyn, J Biller, CS Coffey, BL Hoh, EC Jauch, ... Stroke 46 (10), 3020-3035, 2015 | 1478 | 2015 |
| β-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction DT Ko, PR Hebert, CS Coffey, A Sedrakyan, JP Curtis, HM Krumholz Jama 288 (3), 351-357, 2002 | 748 | 2002 |
| Very early hypothermia induction in patients with severe brain injury (the National Acute Brain Injury Study: Hypothermia II): a randomised trial GL Clifton, A Valadka, D Zygun, CS Coffey, P Drever, S Fourwinds, ... The Lancet Neurology 10 (2), 131-139, 2011 | 612 | 2011 |
| American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association focused update of the 2013 guidelines for the early management of … WJ Powers, CP Derdeyn, J Biller, CS Coffey, BL Hoh, EC Jauch, ... Stroke 46 (10), 3020-3035, 2015 | 497 | 2015 |
| Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease JH Kang, DJ Irwin, AS Chen-Plotkin, A Siderowf, C Caspell, CS Coffey, ... JAMA neurology 70 (10), 1277-1287, 2013 | 420 | 2013 |
| The Parkinson's progression markers initiative (PPMI)–establishing a PD biomarker cohort K Marek, S Chowdhury, A Siderowf, S Lasch, CS Coffey, ... Annals of clinical and translational neurology 5 (12), 1460-1477, 2018 | 380 | 2018 |
| Trial of amitriptyline, topiramate, and placebo for pediatric migraine SW Powers, CS Coffey, LA Chamberlin, DJ Ecklund, EA Klingner, ... New England Journal of Medicine 376 (2), 115-124, 2017 | 349 | 2017 |
| Natural history of infantile‐onset spinal muscular atrophy SJ Kolb, CS Coffey, JW Yankey, K Krosschell, WD Arnold, SB Rutkove, ... Annals of neurology 82 (6), 883-891, 2017 | 338 | 2017 |
| Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy SC DUTTA, JA SMITH, SB SHAPPELL, CS COFFEY, SAMS CHANG, ... The Journal of urology 166 (2), 490-493, 2001 | 337 | 2001 |
| Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease D Weintraub, T Simuni, C Caspell‐Garcia, C Coffey, S Lasch, A Siderowf, ... Movement Disorders 30 (7), 919-927, 2015 | 327 | 2015 |
| Health related quality of life assessment after radical cystectomy: comparison of ileal conduit with continent orthotopic neobladder SC Dutta, SS Chang, CS Coffey, JA Smith, G Jack, MS Cookson The Journal of urology 168 (1), 164-167, 2002 | 284 | 2002 |
| Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel OH Del Brutto, KL Roos, CS Coffey, HH García Annals of Internal Medicine 145 (1), 43-51, 2006 | 277 | 2006 |
| Phase 2 trial of ibudilast in progressive multiple sclerosis RJ Fox, CS Coffey, R Conwit, ME Cudkowicz, T Gleason, A Goodman, ... New England Journal of Medicine 379 (9), 846-855, 2018 | 265 | 2018 |
| Changes in antibiotic prescribing for children after a community-wide campaign JF Perz, AS Craig, CS Coffey, DM Jorgensen, E Mitchel, S Hall, ... Jama 287 (23), 3103-3109, 2002 | 244 | 2002 |
| Detection of gene× gene interactions in genome-wide association studies of human population data SK Musani, D Shriner, N Liu, R Feng, CS Coffey, N Yi, HK Tiwari, ... Human heredity 63 (2), 67-84, 2007 | 221 | 2007 |
| Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF GL Gadbury, CS Coffey, DB Allison Obesity Reviews 4 (3), 175-184, 2003 | 208 | 2003 |
| Adaptive trial designs: a review of barriers and opportunities JA Kairalla, CS Coffey, MA Thomann, KE Muller Trials 13, 1-9, 2012 | 205 | 2012 |
| Adverse effects of β-blocker therapy for patients with heart failure: a quantitative overview of randomized trials DT Ko, PR Hebert, CS Coffey, JP Curtis, JAM Foody, A Sedrakyan, ... Archives of internal medicine 164 (13), 1389-1394, 2004 | 194 | 2004 |
